COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,833 Articles (22,553 medRxiv, 8,280 bioRxiv)

Most recent first Previous |  Page 2220: Articles 22191-22200  | Next

Estimating COVID-19 contribution to total excess mortality
Pimenoff, V. N., Elfstrom, M., Baussano, I., Bjornstedt, M., Dillner, J.
10.1101/2020.09.10.20191965 — Posted: 2020-09-11
Seroprevalence of SARS-CoV-2 Antibodies Among 925 Staff Members in an Urban Hospital Accepting COVID-19 Patients in Osaka Prefecture, Japan
Nishida, T., Iwahashi, H., Yamauchi, K., Kinoshita, N., Okauchi, Y., Suzuki, N., Inada, M., Abe, K.
10.1101/2020.09.10.20191866 — Posted: 2020-09-11
Development, clinical translation, and utility of a COVID-19 antibody test with qualitative and quantitative readouts
Bortz, R. H., Florez, C., Laudermilch, E., Wirchnianski, A. S., Lasso, G., Malonis, R. J., Georgiev, G. I., Vergnolle, O., Herrera, N. G., Morano, N. C., Campbell, S. T., Orner, E. P., Mengotto, A., Dieterle, M. E., Fels, J. M., Haslwanter, D., Jangra, R., Celikgil, A., Kimmel, D., Lee, J. H., Mariano, M., Nakouzi, A., Quiroz, J., Rivera, J., Szymczak, W. A., Tong, K., Barnhill, J., Forsell, M. N., Ahlm, C., Stein, D. T., Pirofski, L.-a., Goldstein, D. Y., Garforth, S. J., Almo, S. C., Daily, J. P., Prystowsky, M. B., Faix, J. D., Fox, A. S., Weiss, L. M., Lai, J. R., Chandran, K.
10.1101/2020.09.10.20192187 — Posted: 2020-09-11
Distinct regimes of particle and virus abundance explain face mask efficacy for COVID-19
Cheng, Y., Ma, N., Witt, C., Rapp, S., Wild, P., Andreae, M. O., Pöschl, U., Su, H.
10.1101/2020.09.10.20190348 — Posted: 2020-09-11
SARS-CoV-2 Antibody Formation Among Healthcare Workers
Birch, T., Barkama, R., Tyszkiewicz Georgescu, J., Yamada, E., Olsen, D., Torres, E., Sinclair, A.
10.1101/2020.09.10.20192104 — Posted: 2020-09-11
Mitochondrial induced T cell apoptosis and aberrant myeloid metabolic programs define distinct immune cell subsets during acute and recovered SARS-CoV-2 infection
Thompson, E., Cascino, K., Ordonez, A., Zhou, W., Vaghasia, A., Hamacher-Brady, A., Brady, N., Sun, I.-H., Wang, R., Rosenberg, A., Delanoy, M., Rothman, R. E., Fenstermacher, K., Sauer, L., Shaw-Saliba, K., Bloch, E. M., Redd, A., Tobian, A. A., Horton, M., Smith, K., Pekosz, A., D'Alessio, F., Yegnasubramanian, S., Ji, H., Cox, A. L., Powell, J. D.
10.1101/2020.09.10.20186064 — Posted: 2020-09-11
Mortality and risk factors among US Black, Hispanic, and White patients with COVID-19
Jun, T., Nirenberg, S., Kovatch, P., Huang, K.-l.
10.1101/2020.09.08.20190686 — Posted: 2020-09-11
Bacterial pulmonary superinfections are associated with unfavourable outcomes in critically ill COVID-19 patients
Buehler, P. K., Zinkernagel, A. S., Hofmaenner, D. A., Wendel Garcia, P. D., Acevedo, C. T., Gomez-Mejia, A., Mairpady Shambat, S., Andreoni, F., Maibach, M., Bartussek, J., Hilty, M., Frey, P. M., Schuepbach, R. A., Brugger, S. D.
10.1101/2020.09.10.20191882 — Posted: 2020-09-11 Discussion: Offsite
Resurgence of SARS-CoV-2 in England: detection by community antigen surveillance
Riley, S., Ainslie, K. E. C., Eales, O., Walters, C. E., Wang, H., Atchison, C. J., Fronterre, C., Diggle, P. J., Ashby, D., Donnelly, C. A., Cooke, G., Barclay, W., Ward, H., Darzi, A., Elliott, P.
10.1101/2020.09.11.20192492 — Posted: 2020-09-11
Hyaluronan is abundant in COVID-19 respiratory secretions
Kaber, G., Kratochvil, M. J., Burgener, E. B., Peltan, E. L., Barlow, G., Yang, S., Nicolls, M. R., de Jesus Perez, V., Rosser, J. I., Wardle, A. J., Kalinowski, A., Ozawa, M. G., Regula, D. P., Nagy, N., Heilshorn, S. C., Milla, C. E., Rogers, A. J., Bollyky, P. L.
10.1101/2020.09.11.20191692 — Posted: 2020-09-11

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).